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Abstract
Background: International targets for access to antiretroviral therapy (ART) have over-estimated the capacity of health
systems in low-income countries in Sub-Saharan Africa. The WHO target for number on treatment by end 2005 for Tanzania
was 10 times higher than actually achieved. The target of the national Care and Treatment Plan (CTP) was also not reached.
We aimed at estimating the capacity for ART provision and created five scenarios for ART production given existing resource
limitations.
Methods: A situation analysis including scrutiny of staff factors, such as available data on staff and patient factors including
access to ART and patient losses, made us conclude that the lack of clinical staff is the main limiting factor for ART scale-up,
assuming that sufficient drugs and supplies are provided by donors. We created a simple formula to estimate the number of
patients on ART based on availability and productivity of clinical staff, time needed to initiate vs maintain a patient on ART
and patient losses using five different scenarios with varying levels of these parameters.
Findings: Our scenario assuming medium productivity (40% higher than that observed in 2002) and medium loss of
patients (20% in addition to 15% first-year mortality) coincides with the actual reported number of patients initiated on ART
up to 2008, but is considerably below the national CTP target of 90% coverage for 2009, corresponding to 420,000 on ART
and 710,000 life-years saved (LY’s). Our analysis suggests that a coverage of 40% or 175,000 on treatment and 350,000 LY’s
saved is more achievable.
Conclusion: A comparison of our scenario estimations and actual output 2006–2008 indicates that a simple user-friendly
dynamic model can estimate the capacity for ART scale-up in resource-poor settings based on identification of a limiting
staff factor and information on availability of this staff and patient losses. Thus, it is possible to set more achievable targets.
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Introduction
Despite considerable international funding for antiretroviral
treatment (ART) in heavily HIV-affected low-income countries in
sub-Saharan Africa [1] scaling-up access to ART has been much
slower than expected. The reasons are many and may include the
effect of stigma on patient demand for ART, but is maybe first and
foremost an overestimation of the output capacity of weak health
systems. In its ‘‘3 by 5’’ target for Tanzania, the World Health
Organization (WHO) initially aimed at 220,000 patients on ART
by the end of 2005. This was 10 times higher than the number
actually achieved [2]. Moreover, the fact that patients in sub-
Saharan Africa often seek care at a late stage of the disease [3],
causing a first–year AIDS mortality rate on ART of up to 15%,
was not considered [4,5,6]. Increased emphasis on accountability
makes it necessary for planners and donors to outline more
implementable and achievable plans [7].
At the time the model was created Tanzania had an estimated
adult HIV prevalence of 6.5%, corresponding to 1.4 (uncertainty
range 1.2–1.5) million infected individuals [8]. The incidence of
HIV has stabilised, and assuming a similar incidence over the last
decade, approximately 175,000 people were estimated to be
infected annually and 160,000 new individuals estimated to need
ART every year in order not to die from AIDS [9,10]. The
Government of Tanzania started ART scale-up in mid-2004 in
accordance with the five-year national Care and Treatment Plan
(CTP) [11] developed together with the Clinton Foundation [12],
mainly financed by the Global Fund (GFATM) [13] and President
Bush’s Emergency Plan for AIDS Relief (PEPFAR). The aim of
the CTP is to provide ART for ‘‘as many HIV-infected residents
PLoS ONE | www.plosone.org 1 April 2009 | Volume 4 | Issue 4 | e5294as possible’’, with 420,000 on ART by mid-2009. However, by
February 2008, only 143,000 had been initiated on treatment (pc
NACP).
To show that there are limitations to achieve these targets in
weak health systems, and to demonstrate that it is possible for local
planners in low income countries, to set more achievable targets,
we worked out a simple method to estimate the maximum possible
number of patients that could access ART in Tanzania. Estimates
were based on the number of available clinical staff taking into
account their productivity and consultation time needed to initiate
vs maintain a patient on ART as well as the expected patient
losses. We outline five different scenarios with varying levels of staff
productivity and patient loss using observational data from human
resource monitoring and available data on consultation time and
patient losses derived from on-going ART programs. For a
simplified model, we assumed that drug procurement and
management issues would not be limiting factors during the
implementation period (figure 1). The results therefore show the
number of HIV-positive individuals in Tanzania that maximally
could access ART under each scenario.
Materials and Methods
We first reviewed the national Care and Treatment plan (CTP)
for 2004–2009 including the ART output targets and the number
of new Care and Treatment Centres (CTCs) that are to be
accredited for scaling-up of access to ART.
We then made a situation analysis of the major bottlenecks for
rapid scale-up of access to ART in Tanzania and other low-
income countries including a review of the existing literature,
unpublished documents and verbal information from key
informants. These findings were summarized in a conceptual
framework displaying the main determinants of ART output
(figure 1).
We proceeded to create a formula containing the main factors
for ART output i.e. the number on treatment by the end of each
year, including the number of new and existing patients, the
availability and productivity of clinical staff as well as patient
losses.
Finally, we calculated the ART output and the number of life
years that could be saved for five different scenarios with three
Figure 1. Conceptual model for ART provision. Conceptual framework with the flow of patients and the four major determinants of ART output
in Tanzania.
doi:10.1371/journal.pone.0005294.g001
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first calculations were made in the beginning of 2006 and later
compared with the actual reported number of patients initiated on
ART at the end of February 2008 as well as with the output
planned in the CTP (figure 2). The details of this process are
described below.
The Tanzanian Care and Treatment Plan (CTP)
By mid-2009, the CTP aims to have 420,000 HIV positive
individuals with CD4 counts below 200/ml on ART, and to
monitor 1.3 million patients not yet in need of treatment. It
assumes an annual loss of patients on ART of only 1%, equal to
the age-specific mortality of the general population. To enable this
scale-up, the number of accredited Care and Treatment Centres
(CTCs) in mainland Tanzania (excluding Zanzibar) must increase
from 20 to 240 centres in less than 4 years (table 1).
According to the plan, CTCs should be located at hospitals and
run by treatment teams of 18 staff members including 7
counsellors. The staff requirements for the CTP were derived
from estimating the need for consultation time per patient for the
first and subsequent years on ART for each staff category,
including clinicians, counsellors, pharmacists and laboratory
personnel (table 2). In all around 9,000 full time equivalents of
clinical staff need to be recruited for treatment and monitoring,
1200 of whom should be clinicians (table 2). Clinicians are divided
into prescribing (medical officers with 6 years of training) and
evaluating clinicians (clinical officers with 3 years of training or
assistant medical officers with 5 years of training). The average
consultation time required per first-year patient on ART, is
estimated to 4 hours (2 visits a ` 30 minutes and 9 visits a `
20 minutes) and after the first year, 1.3 hours (4 visits a `
20 minutes) of clinician care per year and patient. Thus, three
Figure 2. ART output. The number of patients on ART in Tanzania according to end of year numbers of WHO’s ‘‘3 by 5’’ initiative and mid-year
numbers of CTP and five scenarios. Finally the reported number of patients initiated on ART as the thick grey line running up till the end of February
2008.
doi:10.1371/journal.pone.0005294.g002
Table 1. Planned number of patients on ART in Tanzania and in brackets the planned number of health care facilities accredited at
the end of each fiscal year (Fy) according to the CTP.
Type of hospital 2004/5 2005/6 2006/7 2007/8 2008/9
Referral & Selected Regional 10,000 (10) 20,000 (10) 30,000 (10) 40,000 (10) 50,000 (10)
Remaining Regional 1,800 (3) 9,600 (13) 17,400 (13) 25,200 (13) 30,000 (13)
District Voluntary & Private 4,200 (7) 34,800 (51) 102,800 (113) 207,600 (175) 340,800 (217)
Total (Fy) 16,000 (20) 64,400 (74) 150,000 (136) 272,800 (198) 420,800 (240)
doi:10.1371/journal.pone.0005294.t001
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post-first year patients As staff is estimated to work 800 hours with
patients per year this translates into 200 first-year patients (newly
initiated on ART) and 600 post-first-year patients annually for
every clinician [11]
Situation analysis and resulting assumptions and
estimates
The annual number of HIV-infected Tanzanians in immediate
need of ART was estimated to 160,000 new individuals assuming
stable incidence rates (as those currently observed) [14]. By
November 2005, 19,600 patients had started ART [2], by March
2006, 35,000, by September 2007, 117,000 by the end December
2007, 136,000 [15] and by the end of February 2008, 143,000 had
been initiated on ART and 277,000 were being monitored (pc
NACP), indicating that the rate of scaling-up access is slower than
predicted by the CTP (figure 2). However, no data is yet available,
on the degree of under- or duplicate reporting, or on the number
of patients lost to follow-up or death. Thus, these figures need to
be estimated based on existing sources of information.
Estimation of staff availability. In our model we assumed
that the availability of staff would be the main limiting factor of
ART scale-up and that clinicians would be the main limiting staff
factor for ART scale-up. HIV patients do not need to see a medical
doctor, but they need to meet clinical staff trained to assess history,
signs and symptoms and who can prescribe and evaluate the effect
of ARV drugs. The IMF-induced hiring freeze of government
health staff in 1993 has resulted in an old workforce where more
than 15% are 50 years or older. The total number of health
workers, of which 65% work in government services, 22% in
private-not-for-profit and 14% in private-for-profit institutions, has
declined from 67,000 in 1995 to 54,000 in 2002 and has been
estimated to fall even further to 49,000 by 2015 [19]. In 2001/2,
only 60% of health staff positions deemed necessary by the
Ministry of Health were filled, and has since declined even further
mainly due to increased demand through a rapid population
increase (pc Dr Njau MoH). The hiring freeze was lifted in 2004,
but due to a continued high attrition rate and the long lag-time to
expand health worker training, only a limited increase of
government staff could be expected up to 2009 since back-
migration or large numbers of health workers returning from
private care are unlikely.
According to the national plan, mainly hospitals should be
accredited CTCs for ART provision, but since there are only
about 190 hospitals suitable for ART provision, most of them in
urban areas, an expansion to primary health care level in rural
areas with even fewer staff per facility will be necessary to reach
high ART coverage. Thus, in contrast to the CTP, we took into
consideration that less staff per facility would be available at the
primary health care level after CTCs have been established at all
available hospitals.
Also, since half of the 1.4 million HIV infected Tanzanians live
in rural areas [20,21], some patients must receive treatment at
primary health care level. Although less than 2% of the patients
will be treated outside hospitals during 2004–2009 we still
included this in our scenarios since it affects the outcome for the
last two years when the expansion to the primary care level has to
take place.
Considering the shortage of medical officers we assumed that
both prescription and evaluation will have to be done by any
clinical staff available and categorized both prescribing and
evaluating clinicians as ‘‘clinicians’’. Using the 2001/2 Ministry
of Health figures of existing clinicians, we calculated the average
number of clinicians per type of health facility and further
assumed, in line with previous estimates [22], that the average
number at each type of facility, from health centres to regional
hospitals, would remain the same from 2002 throughout 2009 in
all scenarios, but that service provision would be scaled-up at the
pace outlined in the CTP (table 1).
Estimation of staff performance. Few clinicians spend all
their HIV working time on ART. Other activities include
voluntary counselling and testing (VCT), condom distribution,
education in schools, prevention of mother-child transmission
(PMTCT), treatment of STIs, palliative care, monitoring of
immune status and treatment of opportunistic infections in
patients not yet qualifying for ART.
In Rufiji district, with an adult HIV prevalence in 2003 of 7%,
similar to the country average, sexually transmitted infections
(STIs) including HIV/AIDS constituted 22% of the burden of
disease (BoD) [16]. It has also been estimated that 35% of all
health staff time in Tanzania should be invested in HIV/AIDS
interventions to reach the Millennium Development Goals
(MDGs) of 40% ART coverage by 2015 [17,18].
Thus, we assumed that that a maximum of 20% of clinicians’ patient time
would be devoted to ART. A higher proportion would affect both other HIV
activites and other priority health interventions as assessed by WHO’s
Commission on Macroeconomics and Health [18]
The CTP expects prescribing and evaluating clinicians to work
800 hours/year and to treat 200 first-year patients (newly initiated
on ART) and 600 post- 1
st-year patients per year [11]. However
Kurowski et al observed that clinicians at Tanzanian government
hospitals and health centres spent an average of 40% of their
working hours on patient care, i.e. 640 hours/year [19], i.e.
160 hours less per year than the 800 hours/year assumed in the
CTP plan.
Table 2. Number of patients in thousands on ART and CD4
monitoring by end of fiscal year in Tanzania; staff
requirements and budget for each fiscal year according to the
CTP.
2004/5 2006/7 2008/9
Number of patients in ’000s
Patients on ART 16 151 423
New patients on ART 16 86 149
Eligible patients 160 160 160
Coverage (% of eligible patients) 10% 54% 93%
On CD4 monitoring 49 454 1269
New patients on CD4 monitoring 49 258 445
Total staff for ART and CD4 monitoring 432 3481 8802
Total staff for ART 228 1861 4804
Clinicians 80 539 1202
Nurses/counsellors 105 971 2690
Total staff for CD4 monitoring 204 1620 3998
Clinicians 76 655 1605
Nurses/counsellors 95 719 1781
Annual budget (million USD) 26 98 207
Antiretroviral drugs+laboratory tests 11 66 147
Salaries* 1 9 24
*The external input into salary costs.
doi:10.1371/journal.pone.0005294.t002
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40% productivity increase corresponding to 900 working hours per year per
clinician was considered a medium productivity scenario and a doubling of the
by Kurowski et al observed productivity would be considered high productivity,
in our scenario analyses
Estimation of mortality rate and loss of patients on
ART. The 1% mortality rate assumed by the CTP is most likely
an underestimation since data from seven ART programmmes
providing ARVs free of charge showed an average mortality of
11% after 6 months [3] while a first-year mortality of 14% was
reported from South Africa [5]. The high initial mortality may
possibly be explained by data both from Tanzania (pc Dr
Kaushuk, Hindu Mandal Hospital, Dar es Salaam) and other
low-income countries [23] indicating that a large part of all
diagnosed HIV patients seek care very late with CD4 counts below
50/ml. However, a study from Uganda found a very high first-
year mortality of 18% even among patients starting ART with
CD4s counts above 50/ml [4]. A study from Botswana of 410
patients on ART with a median follow-up of 44 weeks, found that
24% had been lost to follow-up or death. The reported first-year
survival rate was 79% (95% CI 74–81%) [6]. A recently published
study from the national programme in Malawi confirmed the
findings of a high first year mortality estimated to 18.5% [29].
Hence, we assumed that patients newly initiated on ART would have an
average first-year mortality of 15% in addition to a basic age-specific mortality
of 1% [24].
Hospital-based fee-for-service programmes in Uganda and
Malawi show one-year patient losses of 56% and 59%,
respectively, mainly due to lack of money among patients and
irregular drug supply at health centres [25,26]. Small well-
controlled programs in Malawi and Kenya providing ARVs drugs
free of charge, report annual first-year losses of 10%–22%,
increasing to 30% in Kenya after the second year of ART [27,28].
A meta-analysis shows a program retention rate of 40% among
ARV patients after 2 years in sub-Saharan Africa [23]. The recent
above mentioned study of the Malawi national programme
showed patient losses of around 10% during the first year [29].
Apart from the Malawi study we have not found any other
published data on patient losses from scaled-up national ART
programs in low-income countries in sub-Saharan Africa. In this
study, we assumed both a low loss scenario of 10%, a medium-loss scenario of
20% and a high loss-scenario of 40%.
The conceptual framework
Our situation analysis resulted in a conceptual framework with
four major determinants of ART output in Tanzania (figure 1):
1) staff availability and productivity,
2) patient-related factors including adherence, stigma, education level,
socio-economic situation and family support,
3) management and logistics and,
4) financial resources, drugs and laboratory supplies.
and with two main factors limiting service provision during the
current five-year planning period 2004–2009: 1) the availability
and productivity of clinicians and 2) retention of patients in the
treatment programmes. We assumed an average duration of 9
years from infection to AIDS [30]. Although this figure has lately
been adjusted after new research findings [31] we still retained it as
plans had been based on it and we had to have comparable
figures. Since most patients are initiated on ART when they
already have clinical signs of AIDS, monitoring of immune status
among those in WHO stage I and II will be of limited importance.
In order to reduce the number of uncertain input variables in the
formula, we assumed that donors will provide sufficient manage-
ment support, financial resources, drugs and laboratory supplies
during this initial five-year period (not saying that current levels will
be sufficient in a future scaled-up context) and that it will be
possible to use existing staff for counselling and supportive
functions given the relatively small number of patients currently
enrolled. We also judged that stigma and low awareness would not
affect the demand for services during the implementation period
2004–2009 since attendance of VCT has increased rapidly during
the last years and since many HIV positive women are diagnosed
at antenatal care clinics and make up over 60% of all patients on
ART in Tanzania (pc NACP).) We also assumed that patient
related factors listed above will be largely captured in our patient
loss estimates.
Estimation of the number of patients on ART each year
We constructed a simple dynamic model to estimate the
number of new and post-first-year-patients on ART at the end of
each year based on annual availability and productivity of
clinicians, and, on the proportion of patients lost to follow-up or
death,. The variables in this formula (figure 3) include: first year
mortality, age-specific mortality, other patient losses (loss to follow-up), average
number of clinicians per facility type, time devoted to HAART, new patients/
year, old (post-first-year) patients/year(clinician productivity). The input
values of each variable can easily be changed by entering new data
into a spread sheet. For our scenarios we only varied patient losses,
new patients/year and old patients/year( clinician productivity), but kept
the other variables constant.
‘‘Old’’ (post-first-year) patients retained and under
continued treatment. In the formula (figure 3) the number
of old patients retained is determined by the number of patients on
treatment at the end of the previous year (Ny-1) and the loss of
patients until the end of the year (Lold). Clinician-time available to
care for old patients (Ny-16(1-Lold/2)/Pold) is determined by the
number of these post-first-year patients retained in the ART
program at the beginning of each year (Ny-1), multiplied with the
proportion of old patients retained after an average of half a year
(assuming that patient loss-to-follow-up or death is equal
throughout the year and thus the average time in the program
for a patient that drops out for one reason or the other is 6 months)
(1-Lold/2), divided by clinician productivity measured as the
number of old patients a full-time clinician cares for during one
year (Pold). We did not take re-entry of lost patients into account
and consistently use the term ‘‘old’’ patients for all that have been
on ART for more than 1 year.
Total clinician-time (Cy) available for ART care. Total
clinician-time (Cy) available is calculated as the number of
accredited CTCs available to offer ART services a particular year
y (Fy) (table 1), multiplied with the average number of clinicians at
the health facilities (Cave)(table 3) multiplied with the proportion
of time clinicians devote to ART of their total working time
(TART) (table 4).
‘‘New’’ (first-year) patients recruited for ART. The
number of new patients that can be recruited depends on 1) the
productivity of clinicians 2) the consultation time clinicians need
for ‘‘old’’ (i.e. post-first-year) and how much time is left over for the
new patients after the ‘‘old’’ patients have been treated 3) how
much time is needed to initiate a new patient on ART (i.e.
4 hours/year according to the CTP). The number of new patients
retained at the end of each calendar year is thus determined by: 1)
the amount of clinician-time available for recruitment of new
patients multiplied with 2) the number of new patients per
clinician year (Pnew), multiplied with the proportion of new
ART Limitations - Tanzania
PLoS ONE | www.plosone.org 5 April 2009 | Volume 4 | Issue 4 | e5294patients remaining after on average half a year on treatment
(1-Lnew/2).
We calculated the number of patients per clinician per year,
both for the first year of treatment and the following years. Total
ART output was defined as the sum of outputs from all accredited
ART facilities that year. ART coverage was defined as the annual
number of new patients initiated on ART divided by the estimated
number of 160,000 eligible new HIV-infected individuals that
annually need ART.
The scenarios
Based on our situation analysis, the resulting assumptions and
the above-defined formula, we created five scenarios with varying
levels of staff productivity and patient loss, to demonstrate the effect on
the number patients that could access ART (ART output) in
Tanzania.
Using results from Kurowski et al [19] who observed 640
working hours/year/clinician, divided by 4 hours total clinician
consultation time per year per new ART patient and 1.3 hours per
patient for each subsequent year on ART respectively as assumed
for the CTP, we outlined a low productivity scenario of 160 (640/4)
first-year patients (Pnew) or 480 (640/1.3) post-first-year patients
(Pold) per working year per clinician. If productivity is raised by
40%, defined as medium productivity i.e. to 900 working hours per year
per clinician, the input per year per clinician is 225 first-year
patients or 675 post- first-year patients. If productivity is doubled,
defined as high productivity, 320 first-year patients or 960 post-first-
year patients would be treated per clinician per year.
Low loss is defined by age-specific mortality 1%+first year
mortality 15% and patient losses due to other causes of 10%.
Medium loss is defined by age-specific mortality 1%+first year
mortality 15% and patient losses due to other causes of 20%. High
loss is defined by age-specific mortality 1%+first year mortality
15% and patient losses due to other causes of 40% (table 4).
Number of AIDS deaths and life years saved. We also
estimated the effect both of the CTP and the five scenarios on the
number of projected AIDS deaths (figure 4). The number of new
AIDS deaths were generated by entering the Estimation and
Table 3. Actual and authorized number of clinicians at different types of health facilities in Tanzania in the fiscal year 2001/2.
Type of health facility Number of facili-ties
Actual mean number
per facility (Cave)
Authorized mean
number per facility
Actual number
per type *
Authorized number
per type **
Referral Hospitals 4 39 58 157 232
Regional Hospitals*** 19 15 8 287 152
District Hospitals 184 11 21 2053 3864
Health centers 397 3 4 1016 1588
TOTAL 604 5.8 9.7 3513 5836
*Ministry of Health/Civil Service Department Staffing levels for health facilities/institutions. Dar es Salaam 1999.
**Ministry of Health, Census of Human Resources for Health for 2001/2.
***Includes one military hospital.
doi:10.1371/journal.pone.0005294.t003
Figure 3. Formula for the calculation of ART output.
doi:10.1371/journal.pone.0005294.g003
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sites in Tanzania of the latest surveillance round 2005/6 [10] into
the Spectrum model [9]. The number of patients initiated on ART
(new patients) according to the CTP and the four scenarios were
then deducted from the projected new AIDS deaths without ART
to calculate the effect of ART implementation. Life-years (LY)
saved were defined as the sum of half of the patient-years saved for
1
st year-patients, i.e. the average of six months saved per year,
Table 4. Input estimates for productivity and losses and outcomes obtained mid-year 2009 for the five scenarios and the CTP
based on the formula.
PLAN AND SCENARIOS CTP
Low prod-low
losses
Low prod-medium
losses
Medium prod-
medium losses
Medium prod-
high losses
High prod- high
losses
INPUT
Time for ART - % of full time TART 100% 20% 20% 20% 20% 20%
New patients/clinician-year 1
st year Pnew 200 160 160 225 225 320
Old patients/clinician-year after 1
st year Pold 600 480 480 675 675 960
Lost patients first year* Lnew 1% 26% 36% 36% 56% 56%
Lost patients after 1
st year** Lold 1% 11% 21% 21% 41% 41%
OUTPUT
Coverage in 2009 93% 25% 27% 38% 41% 58%
No on treatment in 2009 420,000 140,000 125,000 176,000 138,000 251,000
LYs saved 2004–2009 710,000 287,000 254,000 358,000 274,000 509,000
AIDS deaths without access to ART 2004–
2009***
380,000 642,000 639,000 574,000 579,000 485,000
*includes age-specific mortality of 1%+losses to follow-up and non-adherence+1
st year AIDS mortality.
**includes age-specific mortality of 1%+losses to follow-up and non-adherence.
***total number of AIDS deaths minus the sum of the number of new patients per year 2004–2009.
doi:10.1371/journal.pone.0005294.t004
Figure 4. AIDS deaths. Estimated number of AIDS deaths without ART from 1999 to 2009 and with ART according to the five scenarios and to the
CTP from 2004 to 2009.
doi:10.1371/journal.pone.0005294.g004
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years saved for old patients during the same period.
We also made a sensitivity analysis for patient losses, number of
clinicians, and first- year mortality.
Results
Figure 2 displays the maximum number of HIV positive
individuals that could be treated with ART (ART output) in
Tanzania in five different scenarios with the current human
resource capacity and planned pace of accreditation of new
treatment centres, varying staff productivity and patient loss. Our
estimations are displayed together with the initial WHO plan and
national Care and Treatment Plan (CTP) targets for ART scale-up
in Tanzania during 2004–2009 for comparison. Input and
outcome values for the five scenarios, the WHO plan and CTP
are shown in table 4.
The productivity and patient loss assumptions have been
defined in detail in the Methods section. In all scenarios a first-
year mortality of 15% and an age-specific mortality of 1% was
assumed, but the loss due to other causes, such as loss-to follow-up
or drop-out from treatment, varied from 10% (low), to 20%
(medium) up to 40% (high) loss.
The first scenario; ‘‘low productivity-low loss’’, assumes that
productivity remains at the level observed in 2003 [19] with a low
rate of patient loss. If this scenario would be implemented, 140,000
would be on HIV treatment by mid-2009, reaching an ART
coverage of 25% (table 4). Continued low productivity means
clinical staff would devote a large proportion of their time to those
already on ART (old patients) (100,000) and enrollment of new
patients during 2009 would remain low (40,000). The number of
life-years (LYs) saved (287,000), during 2004–2009 would mainly
reflect prolonged survival of patients already enrolled. Around
80% of HIV-positive individuals who progress to AIDS will die
from the disease during the same planning period, without having
been initiated on ART (figure 4).
The second scenario; ‘‘low productivity-medium loss’’, shows
the outcome of continued low productivity but with a slightly
higher level of patient loss. This would lead to a slightly higher
ART coverage of 27% in 2009, as the higher loss of previously
enrolled patients would enable more new patients to be enrolled
but the number of LYs saved would be lower at 254,000 (Table 4).
The proportion of all who develop AIDS and die without having
been initiated on ART would remain as high as 80% (figure 4).
If productivity is increased by 40% as in our third scenario, the
‘‘medium productivity-medium loss’’, ART coverage would
increase to 38% in 2009. The number of new HIV patients
recruited for ART in 2009 could increase to 61,000 while 115,000
previously enrolled patients could be maintained on treatment (not
shown in table). The number of LYs saved would be a little over
350,000.
If we use the productivity figures of the CTP of 200 and 600
patients per year for first and post-first year patients respectively
and assume medium losses, the results are similar with a coverage
of 38% and a number of LYs saved of 320.000
If the fourth ‘‘medium productivity-high loss’’ scenario would
materialise, which assumes a 40% patient loss due to other causes
than death, ART coverage would increase to 41% in line with the
discussion above. The number of LYs saved would decrease to
274,000 (table 4).
The fifth scenario ‘‘high productivity-high loss’’ assumes that
clinicians become twice as productive, i.e. that they either double
their working time or double the number of patients seen without
increasing the number of hours. This scenario would result in
251,000 of those in need having access to ART corresponding to a
58% ART coverage in 2009, 500,000 LYs would have been saved
and an equal number of people dying without having had access to
ART (table 4).
Assuming figures on first year mortality of 18.5% and patient
losses of 10% observed in Malawi [29] and still that three times
more hours are put into treating first year patients than into
treatment of patients after the first year and an output of the
reported number of patients initiated on ART of 143.000 in
February 2008 the average staff production would be 210 first year
and 630 post-first year patients per year. This corresponds well
with our medium productivity scenarios but with a lower loss rate.
Figure 4 shows the proportion of new patients that will get
access to ARV according to the five scenarios out of the 160,000
HIV infected estimated to develop AIDS every year in Tanzania.
The numbers in the figure are derived from our scenario
calculations and based on the assumptions that resources first will
be devoted to previously enrolled patients and that the current
productivity level remain constant.
Thus, Table 4 and Figure 4 shows that if the CTP was
implemented, 420,000 patients would be on ART and 710,000
LYs will be saved by 2009. Meanwhile, another 380,000 will die
from AIDS during 2004–09 without having accessed ART (table 4)
If the medium productivity-medium loss or the medium
productivity–high loss scenarios were implemented, the number
of AIDS deaths would be reduced by 40% from 160.000 to around
95.000. Thus, most infected people would still die without ever
having had access to ART.
A sensitivity analysis for the parameters patient losses (losses due
to other causes such as loss to follow-up), first year mortality and the
average number of clinicians per facility type was performed. It shows that
a 1% change in the average number of clinicians directly translated into
a corresponding 1% change in ART output irrespective of
scenario. A 1% change in patient losses resulted in 0.1% change
in ART output in the low productivity-low loss-scenario, a 0.2%
change in medium loss scenarios and a 0.5% change in the high
loss scenarios. A 1% change in first year mortality resulted in a very
small change of service output, less than or equal to 0.1% in all five
scenarios.
Discussion
We aim to estimate the capacity for ART provision in
Tanzania. Using a simple user-friendly model we are able to
demonstrate that the current plans of scaled-up access to ART in
Tanzania were never feasible. Reality also shows that the
implementation of ART is progressing at a slower pace than
foreseen in the national Care and Treatment Plan (CTP). This
papers shows both that the major reasons why targets have not
been reached, are that the current plans assume a constant
availability of sufficient staff and that the loss of patients on ART
has not been taken into account and that it is possible to estimate
achievable targets if a limiting staff factor can be identified.
Our estimations suggest that around 175,000 patients will be on
ART in Tanzania by mid 2009, which is 40% of the target in the
CTP (figure 2). The reported number of 143,000 initiated on ART
by end February 2008 may be either an underestimation since
many smaller sites did not sent their reports (pc NACP), or an
overestimation since re-entry at the same or at a different CTC is
not taken into account. Moreover, the reported number available
is an accumulation of patients ever initiated on ARV without
consideration of patients lost to follow-up or death. The exact
actual number of patients on treatment end February 2008 is thus
not known, but the magnitude is likely to be around the number
ART Limitations - Tanzania
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what our medium productivity-medium-loss scenario predicted
two years earlier. This indicates that estimating more achievable
targets based on our assumptions is feasible.
In our model we see the ART provision as a result of staff
productivity and patient losses. We also assumed that possible
weaknesses in management would not be limiting during the
implementation period. The actual production may have been
even smaller if for example poor management capacity limits
scale-up. In the model we did not include that, but estimated what
maximally could be achieved by the existing system under three
main assumptions (figure 1):
– Clinicians (number and productivity) is the main limiting staff
factor. We estimated they would spend 20% of their working
time on ART
– Patient losses (deaths and losses to follow-up) constitute a
measure that also captures the sum of all other patient factors
including stigma, transport etc.
– The other factors, logistics, management and funding are not
limiting during the implementation period
If all these assumptions are in agreement with the actual
findings in a country our estimations should be valid. Variations in
the number of clinicians and staff productivity are captured by the
model as are variations in patient factors through losses. The time
devoted to ART is part of the function.
Setting achievable targets is important for planning including
estimations of resource needs. Even if the CTP is implemented
according to plan with 420,000 on ART in 2009 (fig. 2), this
implies 380,000 potentially avoidable AIDS deaths during 2004–
2009 – a figure which, however, for our scenarios is considerably
higher. Our predictions suggest that the number of projected
AIDS deaths will be reduced by about 40% - from 160,000 to
about 95,000 if implementation follows the medium productivity
scenarios (figure 4) and that potentially avoidable AIDS deaths
instead will be around 575.000 (table 4).
Our analysis indicates that the main limitation for ART scale-
up is the low number and low productivity of clinical staff. The
rapid increase in ART initiations after March 2007 might indicate
that losses are high, making it possible to initiate more new
patients on treatment. However, patient loss does not affect output
as much since losses of previously enrolled patients on ART allows
for recruitment of new patients (table 4), but the effects of patient
losses are larger for the high loss scenarios (see sensitivity analysis
under results).
The shortage of staff limits both recruitment of new patients for
ART and further reduction of the number of AIDS deaths. The
scarcity of trained clinical staff will be further accentuated during
the last two years of the planning period by the expansion of ART
services from hospitals to lower level health centers with much
fewer clinical staff. An increase in the number of clinical staff
available and/or an increase in productivity of existing clinical
staff would be needed to counter the tendency of increase in the
number of avoidable deaths due to AIDS shown in the scenario
curves after 2008 (figure 4). Some reductions might also be
achieved through additional task shifting. However, current
staffing levels are ,60% of the levels authorized by the
government [22]. The employment freeze from 1993 resulted in
a declining cadre of qualified health personnel [21] that is now
over-aged with high attrition. The freeze was lifted in 2004 and the
outputs from training institutions have increased for medical
officers, assistant medical officers and clinical officers [33], but
many of these were recruited from within the workforce and as
recruitment of new staff is a slow process [34] it will take several
years before any real increase in staff numbers can be observed.
The annual population growth of around 800.000 in Tanzania
also leads to a rapid increase in demand for health care. In fact –
and maybe mainly because of this - the staffing levels seem to have
continued to decrease (pc Dr Njau, MoH).
Some of the assumptions may also not be correct. Accurate
estimates for planning of ART require evidence on staff
productivity and patient losses in scaled-up program in highly
affected low-income countries. Such evidence is so far only
available for some parameters from one large national pro-
grammes in sub-Saharan Africa [29] and therefore the staff input
values used in our scenarios are based on findings from smaller
treatment program and studies. Our staff productivity figures are
based on a small sub-study in Tanzania [19].
The CTP targets are more achievable than those set by the
WHO, but our study shows that also CTP underestimated existing
constraints for ART in the Tanzanian health system. A possible
increase in the number of qualified health staff for ART will also
compete with other important health care needs including other
priority HIV interventions, such as male circumcision [35,36],
PMTCT or HIV research projects. But, to reach higher coverage
it is necessary that HIV incidence is reduced [37].
The monitoring of patients not yet eligible for ART (CD4
counts .200) would, according to the CTP, require almost as
many staff as is required to treat patients in acute need of ART
and 30% more clinicians in 2009 (table 2). Thus, if we had
included the CD4 monitoring part of the CTP in our scenarios the
estimated ART coverage would have been even lower. An indirect
conclusion of our study is that ART initiation in Tanzania must be
based on clinical staging rather than on resource-demanding CD4
monitoring using the so called public health approach, also
recommended by WHO for similar contexts [29,38,39].
Our assumption that clinicians rather than nurses, pharmacists
and counselors, will be the main limiting factor for ART scale-up
may be either overly optimistic or overly pessimistic given the lack
of existing evidence of clinician-time requirements for ART
patients, but it does not restrict the use of the model since it can be
applied to any type of limiting staff category.
Our model estimates what maximally could be achieved by the
existing system under the assumptions outlined in the Methods
section. Here we see patient loss as a summary measure that
captures the net effect of all patient related factors including
stigma, socio-economic capacity and transportation costs. These
losses could be seen as a result both of patient factors and health
system/management factors, mainly access to and quality of care.
The loss of patients would be less if the quality services and the
availability of drugs improved. Experiences from other sectors and
from STI-scale-up, indicate that there is a risk of that scaling-up
leads to reduced system effectiveness due to limited management
and logistics capacity [40, Hanson unpublished]. On the other
hand, ART programs could be strengthened through cooperation
with strong NGOs as in Uganda [41], or through public/private
mix - a feasible approach at least in middle-income countries like
Botswana [42]. Thus, alternative providers may become important
if they are more productive than the public service staff. This
increased productivity then has to put into the model.
Although our simple model does not explicitly capture the
function of the system and the effects of scaling up, it has the
advantages that it could be applied to any limiting staff category,
to any country, is based on data that is routinely collected or that
could be collected relatively easily through surveys, and contrib-
utes to the understanding of what factors are critical for ART
provision.
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and reality two years later suggests that it is feasible to outline
achievable scale-up plans also in low resource settings like
Tanzania. The model demands identification of limitimg factors
and gives the magnitude of what can be produced under each
scenario. As improved input data become available the range of
scenarios can be narrowed and the estimations improved. This
would make it possible to further improve planning and resource
allocation.
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